메인메뉴 바로가기 본문 바로가기 하단메뉴 바로가기

정기총회 및 학술대회


대한약국학회 주관하는 교육/행사입니다.

대한약국학회 2023년도 정기총회 및 정기학술대회

데이터 기반 지역약국 약료서비스의 현재와 미래

2023년 11월 26일(일) 10:00~17:00 / 한국과학기술회관 12층 아나이스홀

초록/포스터

Hongseok Bae-A Research on a Case of the Treatment Process for a Patient with Idiopathic Parkinsons Disease

작성일 : 2020-11-27 오후 7:35:15     작성자 : 남윤진     조회수 : 465

A Research on a Case of the Treatment Process for a Patient with 

Idiopathic Parkinson`s Disease From Home Care Good Morning Pharmacy 

Hongseok Bae 1 , Jimi Lim 2 , and M.Kang 3  

College of Pharmacy 1,3 , WS University, Wan-ju 55338, Korea 

Good morning Pharmacy 2 , Seongnam, Korea 

 

Abstract 

Introduction Parkinson's disease (PD) is one of the most common neurodegenerative diseases observed in old 

age  along  with  Alzheimer's  disease.  The  idiopathic  Parkinson's  disease  was  first  described  in  a  book  called 

Essay  on  the  Shaking  Palsy  by  James  Parkinson  in  1817.  Main  symptoms  feature  motor  disorders  such  as 

bradykinesia, resting tremor, rigidity, and walking and balance disorders. Parkinson's disease frequently occurs 

in older people aged 60 or older and is recognized as a comprehensive degenerative disease that also involves 

various non-motor disorders such as cognition, sleep, affect, autonomic nervous system and pain.   

 

Purpose 

The purpose of this study is to examine the main symptoms, early and advanced stages of Parkinson's disease, 

improve the symptoms caused by Parkinson's disease, and check the case to see how drug therapy is actually 

being done to improve the patient's quality of life with minimal side effects. 

 

Method 

Most of the main symptoms of Parkinson's disease are dopamine deficiency in the striatum, and replenishment 

of dopamine is the main way to treat Parkinson's disease. In the early stages of mild symptoms, non-dopamine 

drugs can be started, but if the symptoms progress over time, eventually more effective drugs such as levodopa 

or dopamine agonist are needed. At this time, it is important to select the appropriate medication considering the 

degree of symptoms, age of the patient, and cognitive degradation. Approximately 30 to 50 percent of patients 

begin to experience side effects from dopamine therapy in about five years after Parkinson's medication begins. 

If the patient has any of the above long-term treatment side effects, he/she shall check the type through careful 

medical examination and examination. Analysing the correlation between the timing of drug use and the side 

effects is key to further drug control. 

 

Conclusion 

The patient is a 69-year-old elderly patient who does not need to delay the treatment of levodopa at this age. 

Sensitive to other drugs, including dopamine efficacy drugs, side effects such as confusion, mental illness and 

sleepiness often occur. Therefore, it is thought that a more advantageous levodopa was prescribed in terms of 

safety. 

 

Key word : PD, dopamine, Community pharmacy